FDA Information - July 20, 2008

FDA Advisory Committee OKs Psoriasis Drug Enbrel For Pediatric Use

June 18, 2008 - Topics fda, disease, arthritis, cancer and tuberculosis
A U.S. Food and Drug Administration (FDA) advisory panel on Wednesday recommended the psoriasis drug Enbrel to be approved for pediatric use with moderate-to-severe forms of the skin disease.

Seven panel members from the advisory committee voted in favor of recommending approval while five voted against and one abstained. The panel said the drug appears effective but expressed concerns about increased risks of malignancy and serious infections like tuberculosis

read more >>

FDA Warns Consumers About Online Cancer Treatment Fraud

June 17, 2008 - Topics cancer, fda, cats, australia and blood
The U.S. Food and Drug Administration (FDA) is warning consumers not to buy or use fraudulent cancer "treatments" available on the Internet that come in many forms, including pills, tonics, and creams and are sold under various names.

The federal agency has sent letters warning more than two dozen companies to stop selling false products that claim to prevent or cure cancer. Medicinal products and devices intended to treat cancer must gain FDA approval before they are marketed, the agency said Tuesday

read more >>

FDA Orders New Boxed Warnings On Antipsychotic Drugs Labels

June 17, 2008 - Topics fda, pneumonia, risperdal, zyprexa and pharmaceutical
The U.S. Food and Drug Administration is ordering manufacturers of antipsychotic drugs to include boxed warnings on the products after the agency found that the medications can increase the risk of death in some elderly patients.

These medications reduce the psychotic symptoms of schizophrenia and usually allow the patient to function more effectively and appropriately. However, doctors frequently prescribe them to treat elderly patients with dementia

read more >>

FDA Adds Cancer Warning To Johnson and Johnson's Psoriasis Drug

June 13, 2008 - Topics cancer, fda, disease, genital and safety
The U.S. Food and Drug Administration on Friday said a drug from Johnson & Johnson appears effective at treating a severe skin disease, but warned that its extended use may raise the risk of cancer.

Long-term use of ustekinumab may lead to increased risk of tumor development in psoriasis patients, the federal agency said on its website. The agency added that it still needs more long-term safety data to decide whether the drug increases the risk of cancer

read more >>

Source Of Salmonella-Tainted Tomatoes Still Unknown

June 13, 2008 - Topics salmonella, disease, fda, outbreak and water
The U.S. Food and Drug Administration still hasn't announced the source of salmonella-tainted tomatoes that have sickened 228 people in 23 states.

Although Florida has reported cases of salmonella outbreak, the FDA has declared tomatoes grown in Florida are safe and free from salmonella

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use